Back
Vistagen Therapeutics Stock Price Chart
Big exits started like this. So did Mode
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite
Sell
32
VTGN
Vistagen Therapeutics
Last Price:
$2.39
Seasonality Move:
-0.46%
7 Day Trial
ALL ACCESS PASS
$
7
Sold-out (twice) tech raise for accredited investors only
Disclosure: This offer is only open to accredited investors. Please read the offering circular and related risks at invest.modemobile.com/elite-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VTGN is experiencing slight buying pressure.
Vistagen Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.43 | Sell |
| 20-day SMA: | 2.43 | Sell |
| 50-day SMA: | 2.31 | Buy |
| 200-day SMA: | 2.77 | Sell |
| 8-day EMA: | 2.4 | Sell |
| 20-day EMA: | 2.4 | Sell |
| 50-day EMA: | 2.41 | Sell |
| 200-day EMA: | 2.84 | Sell |
Vistagen Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.01 | Buy |
| Relative Strength Index (14 RSI): | 46.2 | Sell |
| Chaikin Money Flow: | 58763 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.27 - 2.51) | Sell |
| Bollinger Bands (100): | (2.28 - 2.84) | Sell |
Vistagen Therapeutics Technical Analysis
| May 27 | May 28 | May 29 | May 30 | Jun 2 | Jun 3 | Jun 4 | Jun 5 | Jun 6 | Jun 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | Jun | |||||||||
| 27 | 28 | 29 | 30 | 02 | 03 | 04 | 05 | 06 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vistagen Therapeutics Stock
Is Vistagen Therapeutics Stock a Buy?
-
Vistagen Therapeutics share price is 2.34 while VTGN 8-day simple moving average is 2.43, which is a Sell signal.
-
The stock price of VTGN is 2.34 while Vistagen Therapeutics 20-day SMA is 2.43, which makes it a Sell.
-
Vistagen Therapeutics 50-day simple moving average is 2.31 while VTGN share price is 2.34, making it a Buy technically.
-
VTGN stock price is 2.34 and Vistagen Therapeutics 200-day simple moving average is 2.77, creating a Sell signal.
VTGN Technical Analysis vs Fundamental Analysis
Sell
32
Vistagen Therapeutics (VTGN)
is a Sell
Is Vistagen Therapeutics a Buy or a Sell?
-
Vistagen Therapeutics stock is rated a SellThe current Vistagen Therapeutics [VTGN] share price is $2.34. The Score for VTGN is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
Vistagen Therapeutics Stock Info
Market Cap:
67.5M
Price in USD:
2.34
Share Volume:
205.7K
Vistagen Therapeutics 52-Week Range
52-Week High:
4.21
52-Week Low:
1.90
Sell
32
Vistagen Therapeutics (VTGN)
is a Sell
Vistagen Therapeutics Share Price Forecast
-
What is the Vistagen Therapeutics stock price today?The Vistagen Therapeutics stock price is 2.34 USD today.
-
Will VTGN stock go up or go down?Vistagen Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Vistagen Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vistagen Therapeutics is overvalued.
Is Vistagen Therapeutics Stock a Buy?
-
Vistagen Therapeutics share price is 2.34 while VTGN 8-day exponential moving average is 2.40, which is a Sell signal.
-
The stock price of VTGN is 2.34 while Vistagen Therapeutics 20-day EMA is 2.40, which makes it a Sell.
-
Vistagen Therapeutics 50-day exponential moving average is 2.41 while VTGN share price is 2.34, making it a Sell technically.
-
VTGN stock price is 2.34 and Vistagen Therapeutics 200-day simple moving average is 2.84, creating a Sell signal.
Fundamental Analysis of Vistagen Therapeutics
Is Vistagen Therapeutics a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.19 per share, and an increase next year of $0.40 per share.
Technical Analysis of Vistagen Therapeutics
Should I short Vistagen Therapeutics stock?
-
VTGN Moving Average Covergence Divergence (MACD) indicator is 0.01, suggesting Vistagen Therapeutics is a Buy
-
Vistagen Therapeutics Relative Strength Index (RSI) is 46.2, which suggest Vistagen Therapeutics is oversold
-
The Bollinger Bands (25) for Vistagen Therapeutics is (2.27 - 2.51), which suggest Vistagen Therapeutics is a Sell
-
The Bollinger Bands (100) for Vistagen Therapeutics is (2.28 - 2.84), which suggest Vistagen Therapeutics is a Sell
* Vistagen Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.